Skip to main content

and
  1. Article

    Open Access

    A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada

    Health technology assessment (HTA) can be used to make healthcare systems more equitable and efficient. Advances in precision oncology are challenging conventional thinking about HTA. Precision oncology advanc...

    Dean A. Regier, Samantha Pollard, Melanie McPhail, Tania Bubela in npj Precision Oncology (2022)

  2. No Access

    Article

    Allocating healthcare resources to genomic testing in Canada: latest evidence and current challenges

    Precision medicine (PM) informed by next-generation sequencing (NGS) poses challenges for health technology assessment (HTA). To date, there has been limited reimbursement of genomic testing with NGS in Canada...

    Deirdre Weymann, Nick Dragojlovic, Samantha Pollard in Journal of Community Genetics (2022)